🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesHas anyone dealt with tirzepatide cardiovascular safety? Page 4

Has anyone dealt with tirzepatide cardiovascular safety?

carlos_SATX Thu, Sep 18, 2025 at 10:20 PM 41 replies 1,657 viewsPage 4 of 9
SleepDoc_PDX
Member
289
1,234
Sep 2024
Portland, OR
Sep 20, 2025 at 5:53 PM#16

Adding the clinical framing, because it changes how the question reads. It helps to say which part of this you are uncertain about. A precise question gets a precise answer; a general one gets everybody’s favourite anecdote.

Happy to go further on any of that.

Last edited: Sep 20, 2025 at 8:53 PM
29 4pete_nash, hank_denver, carlos_SATX and 26 others
Reply Quote Save Share Report
GenomicsKate
Member
345
1,890
Oct 2024
Cambridge, MA
Sep 20, 2025 at 11:24 PM#17

Clinical perspective, offered as context rather than as advice. Take it one variable at a time. Almost every unanswerable question in these threads is unanswerable because three things changed in the same fortnight, and no amount of subsequent argument can untangle them after the fact.

28 3KristenIndy, MarkLI_maint, Dr.PeteFamMed and 25 others
Reply Quote Save Share Report
anna.melb_AU
Member
678
2,890
Apr 2024
Melbourne, AU
Sep 21, 2025 at 4:55 AM#18
GenomicsKate said:
Almost every unanswerable question in these threads is unanswerable because three things changed in the same fortnight, and no amount of subsequent…

Adding a me-too, because a thread of one person's experience is not much use. Nothing to add that would improve it.

27 2emma_london, tammy_FL, Dr.LipidDallas and 24 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
Dr.EndoEP
Member
267
1,234
Oct 2024
El Paso, TX
Sep 21, 2025 at 10:26 AM#19
GenomicsKate said:
Almost every unanswerable question in these threads is unanswerable because three things changed in the same fortnight, and no amount of subsequent…

There is a second half to this that has not been said yet. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.

26 1Dr.BariatricHTX, LindaRN_retired, tommy_boulder and 23 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Sep 21, 2025 at 3:57 PM#20

Moderator note: a post naming a supplier has been edited. Discuss suppliers in the review sections, not here.

Last edited: Sep 21, 2025 at 5:57 PM
4 4PurityPaulOR, MaxMetOK, MounjBrad and 1 other
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register